Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

James Willhite was an editor with The Wall Street Journal's money & investing team based in London.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

The cable operator reported its first-quarter earnings ahead of Friday's opening bell. Chief executives are warning that big-ticket items will cost more, while travel becomes an early trade-war ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...